← Back to Clinical Trials
Recruiting NCT07148518

NCT07148518 Comparison of Upper and Lower Limb Maximal Exercise Capacities and Arterial Stiffness in Patients With CAD

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07148518
Status Recruiting
Phase
Sponsor Gazi University
Condition Coronary Artery Disease (CAD)
Study Type OBSERVATIONAL
Enrollment 30 participants
Start Date 2025-09-01
Primary Completion 2026-06-09

Trial Parameters

Condition Coronary Artery Disease (CAD)
Sponsor Gazi University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 30
Sex ALL
Min Age 18 Years
Max Age 85 Years
Start Date 2025-09-01
Completion 2026-06-09

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Coronary artery disease (CAD) significantly increases mortality rates in both developed and developing countries. In this condition, the impairment of arterial blood circulation leads to insufficient blood supply to the myocardium during both rest and exercise, resulting in symptoms such as angina pectoris, dyspnea, and fatigue. Patients, particularly due to their fear of experiencing angina pectoris, tend to adopt a sedentary lifestyle. This situation contributes to exercise intolerance and a reduction in exercise capacity among individuals with CAD. A review of the literature reveals a lack of studies investigating upper and lower extremity exercise capacity and the physiological responses during exercise testing in patients with CAD. Therefore, the aim of this study is to compare arterial stiffness, muscle oxygenation, respiratory muscle fatigue, energy expenditure, perceived dyspnea, and fatigue during upper and lower extremity exercise testing in patients with coronary artery disease.

Eligibility Criteria

Inclusion Criteria: * Adults aged 18-85 with coronary artery disease diagnosed by conventional or CT angiography * Clinically stable * Willing to participate Exclusion Criteria: * Heart failure diagnosis * Moderate/severe valvular heart disease * Orthopedic, neurological, or pulmonary conditions limiting exercise testing/capacity * Contraindications per ACSM guidelines * Prior coronary artery bypass graft surgery

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology